The Role of Resting Electrocardiogram in Screening for Primary Prevention of Cardiovascular Diseases in High-Risk Groups
- 55 Downloads
Purpose of Review
We sought to determine whether a role existed for the screening of certain populations with electrocardiogram (ECG) to improve risk stratification and facilitate risk reduction for primary prevention.
Current screening guidelines do not recommend ECG screening for the general population.
While current guidelines, based on the available evidence, do not recommend ECG screening for the general population, in this report, we show that certain groups such as the elderly, those with hypertension, diabetes, or chronic kidney disease, may benefit from screening as a cost-effective means for identifying those at risk for future cardiovascular disease events. However, future studies are needed to standardize ECG markers and further qualify the screening value in these populations.
KeywordsResting ECG Cardiac screening Primary prevention
Compliance with Ethical Standards
Conflict of Interest
Thong Nguyen, George Waits, and Elsayed Z. Soliman declare that they have no conflict of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.WHO EMRO | Health promotion and disease prevention through population-based interventions, including action to address social determinants and health inequity | Public health functions | About WHO. http://www.emro.who.int/about-who/public-health-functions/health-promotion-disease-prevention.html. Accessed December 8, 2017.
- 3.Seballos RJ. Principles of Screening. http://www.clevelandclinicmeded.com/medicalpubs/diseasemanagement/preventive-medicine/principles-of-screening/. Published 2010. Accessed December 9, 2017.
- 4.Chou R, Qaseem A, Biebelhausen J, et al. Cardiac screening with electrocardiography, stress echocardiography, or myocardial perfusion imaging: advice for high-value care from the american college of physicians. Ann Intern Med. 2015;162(6):438–47. https://doi.org/10.7326/M14-1225.CrossRefPubMedGoogle Scholar
- 5.Chou R, Arora B, Dana T, Fu R, Walker M, Humphrey L. Screening asymptomatic adults with resting or exercise electrocardiography: a review of the evidence for the U.S. preventive services task force. Ann Intern Med. 2011;155(6):375–85. https://doi.org/10.1059/0003-4819-155-6-201109200-00006.CrossRefPubMedGoogle Scholar
- 6.•• Shah AJ, Vaccarino V, Janssens ACJW, et al. An electrocardiogram-based risk equation for incident cardiovascular disease from the National Health and nutrition examination survey. JAMA Cardiol. 2016;1(7):779. https://doi.org/10.1001/jamacardio.2016.2173. A well-developed ECG risk equation based on various ECG parameters and patient demographics. CrossRefPubMedGoogle Scholar
- 9.Tervahauta M, Pekkanen J, Punsar S, Nissinen A. Resting electrocardiographic abnormalities as predictors of coronary events and Total mortality among elderly men. Am J Med. 1996;100:641–5. https://ac-els-cdn-com.go.libproxy.wakehealth.edu/S0002934396000423/1-s2.0-S0002934396000423-main.pdf?_tid=d7dfb3e0-cb27-11e7-83ac-00000aacb35d&acdnat=1510875944_bb400814c1a2f49fcaa5416d9ccf88d2. Accessed November 16, 2017.CrossRefPubMedGoogle Scholar
- 11.• Bang CN, Devereux RB, Okin PM. Regression of electrocardiographic left ventricular hypertrophy or strain is associated with lower incidence of cardiovascular morbidity and mortality in hypertensive patients independent of blood pressure reduction – a LIFE review. J Electrocardiol. 2014;47:630–5. https://doi.org/10.1016/j.jelectrocard.2014.07.003. The LIFE study showed an association between ECG strain in patients with LVH and increased cardiovascular events in hypertensive patients. CrossRefPubMedGoogle Scholar
- 13.Van Biesen W, De Bacquer D, Verbeke F, Delanghe J, Lameire N, Vanholder R. The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years. Eur Heart J. 2007;28(4):478–83. https://doi.org/10.1093/eurheartj/ehl455.CrossRefPubMedGoogle Scholar
- 16.• Deo R, Shou H, Soliman EZ, Yang W, Arkin JM, Zhang X, et al. Electrocardiographic measures and prediction of cardiovascular and noncardiovascular death in CKD. J Am Soc Nephrol. 2016;27(2):559–69. https://doi.org/10.1681/ASN.2014101045. CKD patients with increased ECG intervals (PR, QRS, QTc) correlate with adverse cardiovascular events. CrossRefPubMedGoogle Scholar
- 17.• Drawz PE, Babineau DC, Brecklin C, He J, Kallem RR, Soliman EZ, et al. Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC study. Am J Nephrol. 2013;38(6):517–28. https://doi.org/10.1159/000357200. Type 1 diabetics are linked to increased cardiovascular outcomes. CrossRefPubMedPubMedCentralGoogle Scholar
- 18.Soliman EZ, Backlund J-YC, Bebu I, Orchard TJ, Zinman B, Lachin JM, et al. Electrocardiographic abnormalities and cardiovascular disease risk in type 1 diabetes: the epidemiology of diabetes interventions and complications (EDIC) study. Diabetes Care. 2017;40(6):793–9. https://doi.org/10.2337/dc16-2050.CrossRefPubMedGoogle Scholar
- 20.Cardoso CRL, Salles GF, Deccache W. QTc interval prolongation is a predictor of future strokes in patients with type 2 diabetes mellitus. Stroke. 2003;34(9):2187–94. https://doi.org/10.1161/01.STR.0000085084.15144.66.CrossRefPubMedGoogle Scholar
- 21.• Cox AJ, Azeem A, Yeboah J, Soliman EZ, Aggarwal SR, Bertoni AG, et al. Heart rate-corrected QT interval is an independent predictor of all-cause and cardiovascular mortality in individuals with type 2 diabetes: the diabetes heart study. Diabetes Care. 2014;37(5):1454–61. https://doi.org/10.2337/dc13-1257. There is an association between prolonged QTc and all-cause mortality and CVD mortality in type 2 diabetics. CrossRefPubMedPubMedCentralGoogle Scholar
- 22.Pop-Busui R, Evans GW, Gerstein HC, Fonseca V, Fleg JL, Hoogwerf BJ, et al. Effects of cardiac autonomic dysfunction on mortality risk in the action to control cardiovascular risk in diabetes (ACCORD) trial. Diabetes Care. 2010;33(7):1578–84. https://doi.org/10.2337/dc10-0125.CrossRefPubMedPubMedCentralGoogle Scholar
- 24.Okin PM, Devereux RB, Nieminen MS, Jern S, Oikarinen L, Viitasalo M, et al. Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the losartan intervention for endpoint reduction in hypertension (LIFE) study. Circulation. 2006;113(1):67–73. https://doi.org/10.1161/CIRCULATIONAHA.105.569491.CrossRefPubMedGoogle Scholar
- 26.• Edison ES, Yano Y, Hoshide S, Kario K. Association of Electrocardiographic Left Ventricular Hypertrophy with Incident Cardiovascular Disease in Japanese older hypertensive patients. Am J Hypertens. 2015;28(4):527–34. https://doi.org/10.1093/ajh/hpu184. Elderly population with hypertension and LVH are associated with a higher risk of cardiovascular events. CrossRefPubMedGoogle Scholar
- 27.• Fitzmaurice DA, Mccahon D, Baker J, et al. Is screening for AF worthwhile? Stroke risk in a screened population from the SAFE study. Fam Pract. 2014;31(3):298–302. https://doi.org/10.1093/fampra/cmu011. This randomized cohort study found approximately 37% new cases of atrial fibrillation with a CHADS2 score of one or greater in the elderly population. CrossRefPubMedGoogle Scholar
- 28.• Almahmoud MF, O’Neal WT, Qureshi W, Soliman EZ. Electrocardiographic versus echocardiographic left ventricular hypertrophy in prediction of congestive heart failure in the elderly. Clin Cardiol. 2015;38(6):365–70. https://doi.org/10.1002/clc.22402. This population-based cohort study found that LVH was associated with increased rates of heart failure in the elderly population. CrossRefPubMedGoogle Scholar
- 29.• O’neal WT, Almahmoud MF, Qureshi W, Soliman EZ. Electrocardiographic and Echocardiographic Left Ventricular Hypertrophy in the Prediction of Stroke in the Elderly. J Stroke Cerebrovasc Dis. 2015;24(9):1991–7. https://doi.org/10.1016/j.jstrokecerebrovasdis. This population-based cohort study found correlations between LVH and stroke. CrossRefPubMedPubMedCentralGoogle Scholar
- 30.Mureddu GF, Tarantini L, Agabiti N, Faggiano P, Masson S, Latini R, et al. Evaluation of different strategies for identifying asymptomatic left ventricular dysfunction and pre-clinical (stage B) heart failure in the elderly. Results from “PREDICTOR”, a population based-study in central Italy. Eur J Heart Fail. 2013;15(10):1102–12. https://doi.org/10.1093/eurjhf/hft098.CrossRefPubMedGoogle Scholar
- 33.Moons KGM, Bots ML, Salonen JT, et al. Prediction of stroke in the general population in Europe (EUROSTROKE): is there a role for fibrinogen and electrocardiography? J Epidemiol Community Heal. 2002;56:30–6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1765507/pdf/v056p00i30.pdf. Accessed December 12, 2017CrossRefGoogle Scholar
- 36.Rembold C. Number needed to screen: development of a statistic for disease screening. BMJ. 1998;317:307–11. http://www.bmj.com.go.libproxy.wakehealth.edu/content/bmj/317/7154/307.full.pdf. Accessed January 14, 2018.CrossRefPubMedPubMedCentralGoogle Scholar
- 37.EKGs and Exercise Stress Tests | Choosing Wisely. http://www.choosingwisely.org/patient-resources/ekgs-and-exercise-stress-tests/. Accessed January 14, 2018.
- 39.Lindholm LH, Ibsen H, Dahlöf B, Devereux RB, Beevers G, de Faire U, et al. Cardiovascular morbidity and mortality in patients with diabetes in the losartan intervention for endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):1004–10. https://doi.org/10.1016/S0140-6736(02)08090-X.CrossRefPubMedGoogle Scholar
- 40.• O’Neal WT, Mazur M, Bertoni AG, et al. Electrocardiographic predictors of heart failure with reduced versus preserved ejection fraction: the multi-ethnic study of atherosclerosis. J Am Heart Assoc. 2017;6(6):e006023. https://doi.org/10.1161/JAHA.117.006023. Several ECG parameters are consistent with systolic heart failure and other ECG parameters are associated with diastolic heart failure. CrossRefPubMedPubMedCentralGoogle Scholar